Researchers at the University of Birmingham, United Kingdom, found that CD248 — a surface marker expressed on fibroblast cells in the lung — might also serve as a marker of disease severity in patients with idiopathic pulmonary fibrosis (IPF). The findings also indicate that CD248 might be a suitable…
In this video from Thorax (the youtube channel of Thorax journal), watch Professor Viswanathan (Nati) Natarajan, from the University of Illinois, Chicago, talk about idiopathic pulmonary fibrosis, a chronic and progressive lung disease for which the prognosis is poor and diagnosis is difficult to conduct. Prof. Viswanathan’s…
Early pulmonary rehabilitation is extremely important to idiopathic pulmonary fibrosis patients. Thorax shared this video in 2014, where Julia Bott, Respiratory Care Team, Surrey PCT, explains the importance of pulmonary rehabilitation and the impact it can have on patients. Learn more about…
In this video from Thorax, shared in late 2014, watch Hilary Pinnock, a respiratory physician from Allergy and Respiratory Research Group, United Kingdom, discuss some facts about the difficulties of diagnosing idiopathic pulmonary fibrosis in primary care. Learn more about pulmonary…
The Lung Institute shared this inspirational video, where you can Joseph O’s pulmonary fibrosis story. In the early stages of dealing with the disease, Joseph had to be on oxygen all the time and he had trouble walking without being breathless. Walking up the…
“This is not a story of death, it’s a story of life”. These are the words Travis Murphy, whose mother died unexpectedly from a brain aneurism, shares with us about his story. After the devastating death of his mom, Travis – along with his family – made the decision…
Researchers at the University of Southampton used an advanced, 3-D X-ray imaging technology for a first time on lung tissue samples from idiopathic pulmonary fibrosis (IPF) patients, gaining a better understanding of how the aggressive lung disease develops in the body. The study, “Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis” was published…
Meet Aisha Chaudhary. In this video, shared by TEDx Talks in 2014, watch this 17-year-old young lady talk about her life and how she never let herself be sad, always choosing to be happy and living the moment. Aisha was born with an immune deficiency…
Thorax shared this video in 2014, where Lisa Spencer, a respiratory physician from Aintree Chest Centre, Aintree Hospital, Liverpool, discusses some of the possible issues of patient access to specialized idiopathic pulmonary fibrosis (IPF) centers and also the access to trial participation.
Karos Pharmaceuticals recently announced that its small molecule drug candidate, KAR5585, has advanced in Phase 1 clinical testing. The drug is being developed for the treatment of pulmonary arterial hypertension (PAH) and other diseases characterized by extensive fibrosis. KAR5585 received Orphan Drug designation for the treatment of PAH by the U.S. Food and Drug Administration…
Get regular updates to your inbox.
